SCHEMBL13370752

SCHEMBL13370752

[c]1ccccc1-c1ccc2ncccc2n1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 7/20 0.43
ALDH1A1 P00352 2/20 0.42
CYP3A4 P08684 1/20 0.41
KDM4E B2RXH2 2/20 0.35
MAPT P10636 1/20 0.35
TOP1 P11387 1/20 0.35
NPC1 O15118 4/20 0.34
RAB9A P51151 3/20 0.34
POLB P06746 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
BCHE P06276 1/20 0.33
CYP1A2 P05177 1/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
CASP1 P29466 1/20 0.33
MAPK10 P53779 1/20 0.33
CASP7 P55210 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL713066 0.81 NPC1 (0.47) ALDH1A1KDM4EMAPTNPC1RAB9A
SCHEMBL467101 0.79 RAB9A (0.47) ALDH1A1CYP3A4KDM4EMAPTNPC1
SCHEMBL29663058 0.78 ALDH1A1 (0.54) TGFBR1ALDH1A1CYP3A4KDM4EMAPT
SCHEMBL713792 0.77 ALDH1A1 (0.41) ALDH1A1CYP3A4KDM4EMAPTSMN1; SMN2
SCHEMBL715296 0.75 LMNA (0.52) ALDH1A1CYP3A4KDM4EMAPTTOP1
SCHEMBL15229223 0.73 ALDH1A1 (0.43) TGFBR1ALDH1A1CYP3A4KDM4EMAPT
SCHEMBL17195073 0.73 TOP1 (0.56) TGFBR1ALDH1A1CYP3A4TOP1NPC1
SCHEMBL11992044 0.73 TGFBR1 (0.60) TGFBR1ALDH1A1CYP3A4KDM4ENPC1
SCHEMBL37815 0.72 KDM4E (0.54) ALDH1A1KDM4EMAPTNPC1RAB9A
SCHEMBL21352271 0.72 KDM4E (0.52) TGFBR1ALDH1A1CYP3A4KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2513059-A1 INHIBITORS OF AKT ACTIVITY Merck Sharp & Dohme Corp. (US) 2012-10-24 EP claimed
EP-2513059-A1 INHIBITORS OF AKT ACTIVITY Merck Sharp & Dohme Corp. (US) 2012-10-24 EP disclosed